Navigation Links
HOYA ConBio Announces Educational Alliance with LVI Global Australia

FREMONT, Calif., Aug. 31 /PRNewswire/ -- HOYA ConBio(TM), a global leader in dental and aesthetic lasers, today announced an agreement with The Las Vegas Institute for Advanced Dental Studies (LVI) Global, an internationally renowned provider of post-graduate dental education, to feature premium dental lasers at LVI Global's first branch in Brisbane, Australia. Effective November 1, this new partnership builds on HOYA ConBio's long-standing involvement at LVI Global's headquarters in Las Vegas.

"We are excited to expand our relationship with LVI Global as they increase their international footprint," said Timothy S. Gehlmann, President & CEO, HOYA ConBio. In the past, the company selected LVI Global headquarters as the host site for the popular HOYA ConBio College for laser dentistry training. More recently, HOYA ConBio lasers have been featured in the Core Curriculum at LVI Global's main teaching facility. "As a major comprehensive dental continuing education program in Australia, this venture validates the worldwide demand for advanced dental laser training."

According to Dr. Anne-Maree Cole, B.D.Sc., LVIM, and Director of LVI Global Australia, the program educates dentists within Australia, New Zealand and Singapore who are interested in advancing their skills in this exciting, complex area of dentistry. With approximately 10,000 practicing dentists in the geographic area -- 83% working in the private sector -- LVI Global Australia addresses a strong and growing market demand.

"Entry into Australia supports our corporate commitment of inspiring dentists around the globe to enhance their practices and quality of care with advanced education and hands-on training," said Dr. Cole "Lasers play a critical role in our curriculum as essential tools for those who want to achieve superior clinical results. We are proud to have HOYA ConBio's lasers in our Australia facility, extending our relationship to new geographic boundaries."

HOYA ConBio's Versa Wave and DioDent Micro 980 lasers will be featured in most of the Core Curriculum of seven sequential programs on Aesthetics, Adhesion and Neuromuscular dentistry. The VersaWave erbium all-tissue laser enhances aesthetic and restorative treatments compromised by discrepancies in how the teeth, bone and soft tissue have erupted. The majority of LVI dentists use the diode soft tissue laser to ensure the gums that frame the smile enhance a finished, balanced and aesthetic result. The Diodent Micro 980 is a next generation laser perfect for this and many other clinical purposes.

About Hoya ConBio: HOYA ConBio designs, manufactures and markets sophisticated laser systems used in dental and aesthetic medical practices worldwide, widely recognized by practitioners as "The World's Most Reliable Lasers(TM)." The company's innovative technologies are highly versatile, clinically effective, and offer rapid return on investment. Headquartered in Fremont, CA, HOYA ConBio maintains a worldwide product and service distribution network. For more information, call 800-532-1064 or visit

About LVI Global: The Las Vegas Institute for Advanced Dental Studies is the world's premier post-graduate dental teaching center, specializing in training aesthetic and neuromuscular dentists. Founded in 1995, LVI was established to educate, guide and support dentists in the delivery of the most advanced patient-based care possible. LVI Global Australia was launched in February 2007. For more information, contact 1.888.584.3237 or visit

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. HOYA ConBio Announces Educational Agreement With LVI Global
2. HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry
3. HOYA ConBio(TM) Introduces VersaWave(R) Specialty Laser
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... Florida Hospital Tampa is the first health ... in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, delivered via ... with a body mass index (BMI) of at least 40 to 45 kg, or a ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... continuing medical education (CME), today announced that the first annual School of Gastrointestinal ... , “The prevention, detection and treatment of gastrointestinal cancers are undergoing transformational change, ...
(Date:12/1/2015)... ... , ... Califia Farms , one of the fastest growing natural beverage ... honors in Beverage World Magazine’s Global Packaging Design Awards, taking home the Gold in ... as a 2015 U.S.A. Taste Champion in the American Masters of Taste Championships for ...
(Date:12/1/2015)... Middletown, PA (PRWEB) , ... December 01, 2015 ... ... separate environments; however, there are professionals who believe that with innovative technologies and ... services allows the patient to get the benefit of a dual-approach to his ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 -- ... the company’s growing product line of food safety and seafood fraud prevention tools. ... nerka) – allow InstantLabs to offer fast, reliable species identification for the four ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... VANCOUVER , Dec. 1, 2015  Following an ... (NASDAQ: OGXI ) announced today that its Phase ... interim futility analysis of the intent-to-treat (ITT) population. In ... identified by the DMC. Both the DMC and OncoGenex ... expected in the second half of 2016, depending on ...
(Date:12/1/2015)... , Dec. 1, 2015  CytoSorbents Corporation (NASDAQ: ... commercializing its CytoSorb® blood purification technology to reduce ... world, today announced that Dr. Phillip Chan ... to participate in the LD Micro Main Event ... Conference, both of which will be held in ...
(Date:12/1/2015)... Colo. , Dec. 1, 2015 /PRNewswire/ ... ) today announced that its Chief Executive ... at the Oppenheimer Annual Healthcare Conference in ... participate in the conference through a webcast ... , --> ...
Breaking Medicine Technology: